Ракетный блок. SRB-A3. [Редактировать]

Технические характеристики

#ХарактеристикаЗначение
1Длина, метра11.68
2Тяга (пустота), кНьютон2305
3Тяга (Земля), кНьютон2150
4Удельный импульс, сек283.6
5Масса, кг75500
6Масса (корпуса), кг9500
7Масса (топлива), кг66000
8Диаметр, метра2.5
9Типтвердотопливный

Найдено 207 документов по запросу «SRB-A3». [Перейти к поиску]


Дата загрузки: 2017-05-21
Скачать документ
Скачать текст
0.03/5
...,029-33,464) 1st Stage SRB* 2nd Stage Option 2nd Stage....4) 19.8 (65) 5 (16.4) 1st Stage SRB* 2nd Stage Option 2nd Stage...,000 (22,046) 1st Stage SRB* 2nd Stage EPC EAP ESC... Stage 4th Stage Length, m (ft) SRB-A3 M-34c KM-V2b Post Boost... (H-IIB)* 2nd Stage 1st Stage SRB-A SRB-A3 2nd Stage 37 (121.4) 15... begin in 2016. The company’s A3 cubesat and Arkyd-100 telescope... 201 Launches 5 Express A2 Express A3 Gorizont 45 SESAT 1 Chinasat 22...



Дата загрузки: 2017-06-15
Скачать документ
Скачать текст
Скачать перевод
Посмотреть билингву
0.25/5
... the Epsilon uses the existing SRB-A3 as a solid rocket booster on...



Дата загрузки: 2016-12-24
Скачать документ
Скачать текст
Скачать перевод
Посмотреть билингву
0.24/5
... the Epsilon uses the existing SRB-A3 as a solid rocket booster on...



Дата загрузки: 2017-06-15
Скачать документ
Скачать текст
0.09/5
...-E 96b Idling. (BvR) YZD6: Tanjug, SRB 1902 RTTY 50b FF nx... w/wx. (BvR) DFZG: MFA Belgrade, SRB 1515 RTTY 75b w/nx in...) 13440 YZI 235: TANJUG BELGRADE, SRB 1353 RTTY w/50/425 nx... (AB) 14674 DFZG: MFA Belgrade, SRB, 1430 RTTY 75b w/RYRY DFGZ.... (MS) 15705 YZI237: Tanjug Belgrade, SRB 1455 RTTY 75b RY. (AB...: M/V Liberty Star 0521 USB NASA SRB recovery ship, wkg "BRD", Booster.... (BvR) YZI 234: Tanjug Belgrade, SRB 1428 RTTY 50b EE nx..., Beyrouth. (PT) DFZG: MFA BELGRADE, SRB 1444 RTTY w/75/425 text...'. (MS) 16302 DFZG: MFA BELGRADE, SRB 1444 RTTY w/75/425 'otvoreni... pallets thru, 3 pallets off-load, A3 for a thrust reverser 4 pax, 80...:div to Rota due to A3 for radar antenna stabilization. pp... eta MPHO (Howard, Panama) 0345, A3: nr.1 INS inop, seems to... embassy. (ANN) Austrian Embassy Belgrade,SRB 1300 SI-ARQ 96b Zirkular... FDY. (DG) Polish Embassy Belgrade,SRB 1135 POL-ARQ 100b w/MFA.... (ANN) YZI 234: TANJUG BELGRADE, SRB 1358 RTTY w/50/425 EE... : E3, E4, E5, E6 So, A3, E6, D7, a vessel that cruises... A7, B7, A1, B2, C2, A3, B3 and C3. The complete....0 SAG C2 6323.0 6272.0 SAG A3 8556.0 8398.5 SAG B3 8419.... (RHB) 12212.5 YZI234: TANJUG BELGRADE, SRB 1854 RTTY 50/425 RYs... review. (MC) DFZG: MFA Belgrade,SRB 1433 RTTY 75b Nx. (AB...-0026 ETA blocks Rota 2049Z A3: Loss No.1 Hydraulic System leading... MF coast station with DSC o A3: within cover of International Marine... areas outside A1, A2 and A3 * Communication Digital Selective Calling (DSC... nx". (HS) YZI234: Tanjug Belgrade, SRB 1240 RTTY 50d "EE nx.../11/95 USB REACH 11 A3 WW Croughton pp Hilda East & Usafmetro tail 50223 A3 pos 37n 18.37e f 330...



Дата загрузки: 2017-06-15
Скачать документ
Скачать текст
0.15/5
.../ air-ground surveillance (admitted) [IMO] [SRB-N(2005)0011] capacité aéroportée de... Group APOD airport of debarkation [A3-D(98)1] [AJP-3.13] Groupe consultatif... Civil Aviation Planning Committee [NASG] [A3-D(98)1] [NASG] chapter, item, sub... of Modern Society [MC 0324] [A3-D(98)1] Commandement de composante terrestre... armements 2 CE Commission européenne [A3-D(98)1] [JOCE] Conference of National... Europe Pipeline Management Agency [NASG] [A3-D(98)1] pétrolier d'escorte de convoi... moyens électroniques et de communication [A3-D(98)1] Organisation de gestion des... Systems Executive Steering Group [NASG] [A3-D(98)1] InterAllied Confederation of Reserve... Information Systems Coordinating Committee [NASG] [A3-D(98)1] [MC 0534] Comité de... of National Armaments Directors [NASG] [A3-D(98)1] radar de contrebatterie Conf... Police Advisory Training Team [NASG] 5 [SRB-DS(2005)0001] CP control... Supervisors of the Provident Fund [A3-D(98)1] CSDR combined ship destination... demonstrator DEPMEDS deployable medical system [A3-D(98)1] [NASG] démonstrateur de fusion...] DHOD deputy head of delegation [A3-D(98)1] DIREX direction d'exercice chef... forces interarmées déployable [NASG] [SRB-D(2005)0008] DISE direct intelligence... DOSO director of staff operations [SRB-N(2005)0028] [NASG] base op... des activités de l'état-major [SRB-N(2005)0028] [NASG] 2 DOB depth...] [NASG] date de début probable [SRB-N(2008)0048] ECTC estimation de... Food and Agriculture Planning Committee 3 [A3-D(98)1] contrôleur air avanc...é tir d'efficacité [NASG] Note: Afghanistan. [SRB-A(2005)0001] FFIR friendly forces... Assistance Force /ISAF/ Note : Afghanistan. [SRB-A(2005)0001] [NASG] besoin d’information... réseau final operational capability (deprecated) [SRB-D(2005)0008] capacité opérationnelle...é opérationnelle finale (déconseillé) [NASG] [SRB-D(2005)0008] FNI forces nucl... GEOREF world geographic reference system [A3-D(98)1] système mondial géographique... initial d'interprétation [AAP-06] [A3-D(98)1] Comité de planification industrielle... par infrarouge [NASG] Note: Afghanistan. [SRB-A(2005)0001] IRT immediate response...é /FIAS/ [NASG] [NASG] Note : Afghanistan. [SRB-A(2005)0001] IRTC internationally recommended... de la navigation commerciale [SRB-N(2005)0011] [NASG] [SRB-N(2005)0011] ISK...: Naval air defence only. [NASG] [SRB-D(2005)0008] réseau local d'entreprise... warfare coordinator antisurface warfare /ASUW/ [SRB-D(2005)0008] [ATP-01] coordonnateur...] Senior NATO Logisticians Conference (obsolete) [A3-D(98)1] 2 LARS light artillery rocket...] ordre de bataille Mer [NASG] [SRB-DS(2005)0001] Commandement multinational... and Control System Management Agency [A3-D(98)1] NA5CRO non-Article 5 crisis... NAAG NATO Army Armaments Group [A3-D(98)1] [A3-D(98)1] Groupe OTAN sur...(2013) NAD national armaments director [A3-D(98)1] NAEGIS NATO airborne early... NATO Air Defence Ground Environment [A3-D(98)1] [MCM-0011-2003] infrastructure... and Logistics Management Agency [AJP-2] [A3-D(98)1] zone d'intérêt désignée Agence...] NAIRN NATO Information Resource Network [A3-D(98)1] [EAPC] Organisation de gestion... Supply Agency [NASG] base aéronavale [A3-D(98)1] [NASG] Agence OTAN d'entretien... 2] système OTAN d'indicateurs d'objet [A3-D(98)1] [NASG] Organisation OTAN d'entretien... non-commissioned officer in charge [SRB-(2005)0008] [NASG] [NASG] sous... de services SIC (toléré) [NASG] [SRB-(2005)0008] NCPR NATO Civilian... structure de forces de l'OTAN [A3-D(98)1] [NASG] Organisation de production... NATO Headquarters C3 Staff [NASG] [A3-D(98)1] zone d'interdiction aérienne Secr... organization NPT Non-Proliferation Treaty [A3-D(98)1] Note: Non-proliferation of... battalion NRP NATO radar plan [SRB-D(2005)0008] [NASG] bataillon OTAN... de l'OTAN sur les radars [SRB-D(2005)0008] [NASG] 1 NSC NATO... – Iraq NTDB NATO Terminology Database [SRB-A(2005)0001] [NASG] Mission OTAN... données terminologique de l’OTAN [SRB-A(2005)0001] [NASG] NTMS NATO... et de reconnaissance opérationnelles [SRB-D(2005)0008] 1 international organization /IO... OOTW operations other than war [SRB-N(2006)0028] [NASG] équipe de... and Logistics Organization /NHPLO/ [NASG] [A3-D(98)1] OP DEF operational defect... PoP point of presence [EPG] [SRB-D(2005)0008] participant principal point de présence [NASG] [SRB-D(2005)0008] PPA parité de... PfP Enhancement SITSUM situation summary [A3-D(98)1] Note: Intelligence. [ATP-61... Level Weapons Protection Group [EPG] [A3-D(98)1] exercice de recherche, d'évacuation... Political Committee 2 SP self-propelled [A3-D(98)1] [NASG] Comité politique de... Committee (reinforced) 3 SP sensitive point [A3-D(98)1] [NASG] Comité politique de...] 3 SR special reconnaissance and surveillance SRB Senior Resource Board Note: Special... statement of requirements [AC/224] [SRB-N(2005)0011] processeur de donn... team 2 TIC toxic industrial chemical [SRB-D(2005)0008] [NASG] équipe de...éâtre (produit) chimique industriel toxique [SRB-D(2005)0008] [NASG] TM tactical... véhicule blindé de combat d'infanterie [A3-D(98)1] [NASG] Comité de coordination...-02] grand réseau [OPLAN 40104] [SRB-D] point de regroupement d'armes réseau...



Дата загрузки: 2017-06-16
Скачать документ
Скачать текст
0.02/5
... 600 cc - ZX 600-A1/A3 NINJA 600 85 > 87 600... 1300 cc - Z 1300 ../ DFI (A2, A3) 74-96 ENG 003463 -> 80... 1300 cc - ZG 1300 G (A1-A3) / ZN 1300 134 X27ESR-U 4116...-U 3070 60 cc AA - 06A2 / A3 / A4 / A5 / A6 91 > W20FSR... cc AC 44 A1 / A2 / A3 W24ESR-U 4033 440 cc AE... 500 cc AB 50 A2 / A3 / A4 W27ESR-U 4045 500 cc... cc AE 50 A1 / A2 / A3 W27ESR-U 4045 500 cc AF... 438 cc 60 : AB 50 A3 HIRTH 246 cc 81R / 82R... - SRB 334 cc 1034 - SRB 339 cc 2046 - SRB 398 cc 2040 - SRB 450 cc 2045 - SRB 539 cc 2054 - SRB 618 cc 2062 - SRB 2034...



Дата загрузки: 2017-06-15
Скачать документ
Скачать текст
0.04/5
... A2 [Al3] (A13): аналоговый вход A3 [RP] (PI): импульсный вход [AI... контроля недогрузки, см. стр. 251 Srb [Частота гистерезиса достигнута] g T Максимальная ошибка... A2 [Al3] (A13): аналоговый вход A3 [Терминал] (LCC): графический или выносной... Updt [Al3] (A13): аналоговый вход A3 LCC [Быстрее-медленнее] (UPdt): управление... A2 [Al3] (A13): аналоговый вход A3 [I двигат.] (OCr): ток двигателя [f двигат... A2 [Al3] (A13): аналоговый вход A3 [Терминал] (LCC): графический или выносной... A2 [Al3] (A13): аналоговый вход A3 [Терминал] (LCC): графический или выносной... A2 [Al3] (A13): аналоговый вход A3 [Имп. вход] (PI): импульсный вход... A2 [Al3] (A13): аналоговый вход A3 [Имп. вход] (PI): импульсный вход... A2 [Al3] (A13): аналоговый вход A3 [Терминал] (LCC): графический или выносной... A2 [Al3] (A13): аналоговый вход A3 [Имп. вход] (PI): импульсный вход... сконфигурированной уставки [Частота гистерезиса достигнута] (Srb). Момент в % ном. момента Между нулевой.../Описание Диапазон настройки Заводская настройка Srb [Частота гистерезиса достигнута] 0.3 - 599 Гц... сконфигурированной уставки [Частота гистерезиса достигнута] (Srb). Релейный или дискретный выход может... ограничения тока для работоспособности функции g T (1) Srb [Частота гистерезиса достигнута] g T Максимальная ошибка...



Дата загрузки: 2017-06-16
Скачать документ
Скачать текст
0.08/5
....1. Proliferation assay........................................................................................................... 92 2.11.2. Sulphorhodamine (SRB) assay ....................................................................................... 93 2.11.3. Annexin V assay... RNA RNase SDS SNP siRNA SRB TEX14 TR TS TFF1 TR... tested MageA genes (MageA1,-A2,-A3, and –A6; data not shown... growth assay. 92 2.11.2. Sulphorhodamine (SRB) assay In addition to cell...-mitochondrial cytotoxicity assay, suphorhodamine assay (SRB) was used to evaluate the... negatively charged pink aminoxanthine dye, SRB by basic amino acids in... more than 5mins. Fifty l of SRB (0.4% in 1% acetic acid) was added... undertaken using the suphorhodamine assay (SRB) to evaluate the effect of... negatively charged pink aminoxanthine dye, SRB by basic amino acids in... less in numbers and by SRB assay as shown in our..., and c12 respectively, by suphorhodamine (SRB) assay. The experiment design included... of cancer patients with MAGE-A3 protein reveals long-term immunological... S (2008). The melanoma-associated antigen A3 mediates fibronectin-controlled cancer progression... of histone 3 modifications targeting MAGE-A3 in pituitary neoplasia. Clin Cancer...



Дата загрузки: 2017-06-15
Скачать документ
Скачать текст
0.12/5
... code 3-character POSITION Variable Format 1 A3 Columns 1-3 VALUE Format value label... SRB: Primary School 6880002 SRB: Gymnasium 6880003 SRB: Technical 6880004 SRB: Technical Vocational 6880005 SRB: Medical 6880006 SRB: Economic 6880007 SRB: Economic Vocational 6880008 SRB: Agricultural 6880009 SRB: Agricultural Vocational 6880010 SRB: Artistic 6880011 SRB... 68812 SRB: North Vojvodina,Gymnasium 68813 SRB: North Vojvodina,Technical 68814 SRB: North Vojvodina,Medical 68815 SRB: North Vojvodina,Economic 68816 SRB: North Vojvodina,Agricultural 68817 SRB: North Vojvodina,Art 68818 SRB: North Vojvodina,Mixed 68822 SRB: South Vojvodina,Gymnasium 68823 SRB: South... 68824 SRB: South Vojvodina,Medical 68825 SRB: South Vojvodina,Economic 68826 SRB: South Vojvodina,Agricultural 68827 SRB: South Vojvodina,Art 68828 SRB: South Vojvodina,Mixed 68832 SRB: Belgrade,Gymnasium 68833 SRB: Belgrade,Technical 68834 SRB: Belgrade,Medical 68835 SRB: Belgrade,Economic 68836 SRB: Belgrade,Agricultural 68837 SRB: Belgrade,Art 68838 SRB: Belgrade,Mixed 68842 SRB: Stig,Gymnasium 68843 SRB: Stig,Technical 68844 SRB: Stig,Medical 68845 SRB: Stig,Economic 68846 SRB: Stig,Agricultural 68847 SRB: Stig,Art 68848 SRB: Stig,Mixed 68852 SRB: Western Serbia,Gymnasium 68853 SRB: Western Serbia,Technical 68854 SRB: Western Serbia,Medical 68855 SRB: Western Serbia,Economic 68856 SRB: Western Serbia,Agricultural 68857 SRB: Western Serbia,Art 68858 SRB: Western Serbia,Mixed 68862 SRB: Central Serbia,Gymnasium 68863 SRB: Central Serbia,Technical 68864 SRB: Central Serbia,Medical 68865 SRB: Central... 68866 SRB: Central Serbia,Agricultural 68867 SRB: Central Serbia,Art 68868 SRB: Central Serbia,Mixed 68872 SRB: East Serbia,Gymnasium 68873 SRB: East Serbia,Technical 68874 SRB: East Serbia,Medical 68875 SRB: East Serbia,Economic 68876 SRB: East Serbia,Agricultural 68877 SRB: East... 68878 SRB: East Serbia,Mixed 68882 SRB: Southern Serbia,Gymnasium 68883 SRB: Southern Serbia,Technical 68884 SRB: Southern Serbia,Medical 68885 SRB: Southern Serbia,Economic 68886 SRB: Southern Serbia,Agricultural 68887 SRB: Southern Serbia,Arts 68888 SRB: Southern Serbia,Mixed 68890 SRB: Primary schools 68891 SRB: Stratum...



Дата загрузки: 2017-06-15
Скачать документ
Скачать текст
0.09/5
Do more, feel better, live longer Annual Report 2012 b GSK Annual Report 2012 Our mission At GSK our mission is to improve the quality of human life by enabling people to do more, feel better and live longer. Notice regarding limitations on Director Liability under English Law Under the UK Companies Act 2006, a safe harbour limits the liability of Directors in respect of statements in and omissions from the Report of the Directors contained on pages 1-136 and 239-244 which includes a business review on pages 1 to 86. Under English law the Directors would be liable to the company, but not to any third party, if the Report of the Directors contains errors as a result of recklessness or knowing misstatement or dishonest concealment of a material fact, but would not otherwise be liable. Report of the Directors Pages 1-136 and 239-244 inclusive comprise the Report of the Directors that has been drawn up and presented in accordance with and in reliance upon English company law and the liabilities of the Directors in connection with that report shall be subject to the limitations and restrictions provided by such law. Website GlaxoSmithKline’s website www.gsk.com gives additional information on the Group. Notwithstanding the references we make in this Annual Report to GlaxoSmithKline’s website, none of the information made available on the website constitutes part of this Annual Report or shall be deemed to be incorporated by reference herein. Alex Szabzon Front cover image A child being seen by a doctor working for Brazil’s unified health system, which provides 95% of scheduled vaccinations in the country. We have a long-standing relationship with the governmentfunded science institution, Oswaldo Cruz Foundation, to manufacture vaccines for public health priorities in Brazil. This began with our first alliance in the 1980s on polio vaccines and continues through to recent technology transfers for products like our pneumococcal vaccine. Brazil is one of a number of large emerging market countries in which we are present and more than a quarter of the Group’s total revenues are now generated in these countries. Cautionary statement regarding forward-looking statements The Group’s reports filed with or furnished to the US Securities and Exchange Commission (SEC), including this document and written information released, or oral statements made, to the public in the future by or on behalf of the Group, may contain forward-looking statements. Forward-looking statements give the Group’s current expectations or forecasts of future events. An investor can identify these statements by the fact that they do not relate strictly to historical or current facts. They use words such as ‘anticipate’, ‘estimate’, ‘expect’, ‘intend’, ‘will’, ‘project’, ‘plan’, ‘believe’ and other words and terms of similar meaning in connection with any discussion of future operating or financial performance. In particular, these include statements relating to future actions, prospective products or product approvals, future performance or results of current and anticipated products, sales efforts, expenses, the outcome of contingencies such as legal proceedings, and financial results. The Group undertakes no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise. Forward-looking statements involve inherent risks and uncertainties. The Group cautions investors that a number of important factors, including those in this document, could cause actual results to differ materially from those contained in any forward-looking statement. Such factors include, but are not limited to, those discussed under ‘Risk factors’ on pages 78-86 of this Annual Report. A number of adjusted measures are used to report the performance of our business. These measures are defined on page 56. Brand names Brand names appearing in italics throughout this report are trademarks either owned by and/or licensed to GlaxoSmithKline or associated companies, with the exception of Boniva/Bonviva, a trademark of Roche, NicoDerm, a trademark of Johnson & Johnson, Merrell, Novartis, Sanofi or GlaxoSmithKline, Potiga, a trademark of Valeant, Prolia and Xgeva, trademarks of Amgen, Vesicare, a trademark of Astellas Pharmaceuticals in many countries and of Yamanouchi Pharmaceuticals in certain countries, Volibris, a trademark of Gilead, Xyzal, a trademark of UCB or GlaxoSmithKline and Zyrtec, a trademark of UCB or GlaxoSmithKline all of which are used in certain countries under licence by the Group. GSK Annual Report 2012 1 Overview Financial review & risk Financial review Financial position and resources Financial review 2011 Risk factors 55 66 72 78 Financial statements Directors’ statement of responsibilities Independent Auditors’ report Financial statements Notes to the financial statements Financial statements of GlaxoSmithKline plc prepared under UK GAAP 88 92 94 95 103 109 110 111 113 127 136 138 139 140 144 218 137-223 ...